Adicet Bio Capital Expenditures Over Time

ACET Stock  USD 0.91  0.05  5.81%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Adicet Bio Performance and Adicet Bio Correlation.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
  
Capital Expenditures is likely to drop to about 3.7 M in 2024.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.70)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.29)
Return On Equity
(0.58)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Capital Expenditures Analysis

Compare Adicet Bio and related stocks such as Edgewise Therapeutics, Talaris Therapeutics, and Cullinan Oncology LLC Capital Expenditures Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
EWTX180 K180 K180 K180 K180 K180 K180 K180 K180 K180 K203 K668 K5.5 M5.7 MM
CGEM0.00.00.00.00.00.00.0261 K261 K20 K10 K589.2 K1.1 M208 K222.1 K
VOR748 K748 K748 K748 K748 K748 K748 K748 K748 K748 K4.2 M3.9 M8.5 M1.1 MM
TNYA2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M9.8 M25.1 M20.6 M1.2 M1.2 M
BCYC244 K244 K244 K244 K244 K244 K244 K1.1 M1.2 M1.6 M1.2 MM19 M2.9 MM
IGMS385 K385 K385 K385 K385 K385 K385 K385 K788 K2.3 M17.5 M13.2 M10.2 M12.4 M8.9 M
GLUE1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M3.4 M9.7 M12.9 M19 M10.2 M
STOK113 K113 K113 K113 K113 K113 K113 K113 K935 K1.6 M1.1 M1.2 MM1.6 M1.7 M
AVTE181 K181 K181 K181 K181 K181 K181 K181 K181 K181 K181 K181 K195 K142 K140.8 K
ACRV15 K15 K15 K15 K15 K15 K15 K15 K15 K15 K15 K238 K2.2 M1.3 MM
ANEB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
AGIO1.9 M1.9 M1.5 M1.3 M2.2 M20.2 M9.9 M4.6 MM12.2 M14.9 M5.7 M4.9 M999 K949 K
NKTX757.9 K757.9 K757.9 K757.9 K757.9 K757.9 K757.9 K757.9 K757.9 K1.9 M7.5 MM47.1 M28.1 M16.6 M
PLRX1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M1.4 M2.3 M964 K1.5 MM1.8 M921 K1.2 M
ALEC2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M801 K1.9 M15.3 MM3.2 M4.1 M2.4 M2.3 M
AADI0.00.00.00.00.041 K113.3 K8.9 K37.9 K237 K19 K46 K444 KM4.2 M
KROS217 K217 K217 K217 K217 K217 K217 K217 K217 K271 K294 KM1.2 M2.5 M2.6 M

Adicet Bio and related stocks such as Edgewise Therapeutics, Talaris Therapeutics, and Cullinan Oncology LLC Capital Expenditures description

Capital Expenditures are funds used by Adicet Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Adicet Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

My Equities

My Current Equities and Potential Positions

Adicet Bio
ACET
Specialization
Health Care, Health Care Equipment & Services
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 0.91

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.